|
1
|
Saylan M, Safak YE, Yenilmez FB, Kockaya G, Tatar M, Hilal VE, Vural IM, Akbulat A, Gursoz H, Artiran G, Kerman S. Impact Of Health Policy Changes on Unit Sales of 5 Top Selling Atc1 Phramaceutical Groups In Turkey. Value Health 2014; 17:A411. [PMID: 27201012 DOI: 10.1016/j.jval.2014.08.972] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Affiliation(s)
- M Saylan
- Health Economics and Policy Association, Ankra, Turkey
| | - Yilmaz E Safak
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | | | - G Kockaya
- Health Economics and Policy Association, Ankra, Turkey
| | - M Tatar
- Hacettepe University, Ankara, Turkey
| | - Vural E Hilal
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - I M Vural
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - A Akbulat
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - H Gursoz
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - G Artiran
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - S Kerman
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| |
Collapse
|
|
2
|
Vural EH, Vural IM, Yigit O, Uman N, Tolun C, Babacan S, Dogan E, Akbulat A, Kahveci R, Malhan S, Artiran G, Kerman S. The Effects of Reforms, Price Cuts and Global Budget Implementation on Biotechnological Medicine Sales Which Have Annual Average Highest Amount Of Sales Between 2008-2013 In Turkey. Value Health 2014; 17:A408. [PMID: 27200997 DOI: 10.1016/j.jval.2014.08.955] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Affiliation(s)
- E H Vural
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - I M Vural
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - O Yigit
- Turkish Statistical Institute, Ankara, Turkey
| | - N Uman
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - C Tolun
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - S Babacan
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - E Dogan
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - A Akbulat
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - R Kahveci
- Ankara Numune Education and Research Hospital, Ankara, Turkey
| | - S Malhan
- Baskent University, Ankara, Turkey
| | - G Artiran
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - S Kerman
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| |
Collapse
|
|
3
|
Kockaya G, Yenilmez FB, Saylan M, Safak YE, Tatar M, Hilal VE, Vural IM, Akbulat A, Gursoz H, Artiran G, Kerman S. Impact of Health Policy Changes on the Growth Locally Manufactured and Imported Pharmaceutical Markets of Top Selling Atc1 Phramaceutical Group (Alimentary and Metabolism (A0) In Turkey. Value Health 2014; 17:A410-A411. [PMID: 27201004 DOI: 10.1016/j.jval.2014.08.969] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Affiliation(s)
- G Kockaya
- Health Economics and Policy Association, Ankra, Turkey
| | | | - M Saylan
- Health Economics and Policy Association, Ankra, Turkey
| | - Yilmaz E Safak
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - M Tatar
- Hacettepe University, Ankara, Turkey
| | - Vural E Hilal
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - I M Vural
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - A Akbulat
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - H Gursoz
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - G Artiran
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - S Kerman
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| |
Collapse
|
|
4
|
Vural IM, Vural EH, Yigit O, Dogan E, Babacan S, Tolun C, Uman N, Akbulat A, Malhan S, Kahveci R, Artiran G, Kerman S. The Effects of Reforms, Price Cuts And Global Budget Implementation on Original/Generic Medicine Sales Which Have Annual Average Highest Amount Of Sales Between 2008-2013 In Turkey. Value Health 2014; 17:A410. [PMID: 27201007 DOI: 10.1016/j.jval.2014.08.966] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Affiliation(s)
- I M Vural
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - E H Vural
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - O Yigit
- Turkish Statistical Institute, Ankara, Turkey
| | - E Dogan
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - S Babacan
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - C Tolun
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - N Uman
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - A Akbulat
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - S Malhan
- Baskent University, Ankara, Turkey
| | - R Kahveci
- Ankara Numune Education and Research Hospital, Ankara, Turkey
| | - G Artiran
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - S Kerman
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| |
Collapse
|
|
5
|
Tanyeri MH, Kockaya G, Tanyeri P, Yenilmez FB, Buyukokuroglu ME, Vural IM, Akbulat A, Artiran G, Kerman S. Incidence Of Unlicensed And Off-Label Prescription In Urologic Cancers Therapy In Turkey: Assessment Of Legislative And Regulatory Policy. Value Health 2014; 17:A472. [PMID: 27201355 DOI: 10.1016/j.jval.2014.08.1343] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Affiliation(s)
- M H Tanyeri
- Yenikent Governmet Hospital, Sakarya, Turkey
| | - G Kockaya
- Health Economics and Policy Manager, Ankara, Turkey
| | | | | | | | - I M Vural
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - A Akbulat
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - G Artiran
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - S Kerman
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| |
Collapse
|
|
6
|
Hilal VE, Kockaya G, Yenilmez FB, Saylan M, Safak YE, Tatar M, Vural IM, Akbulat A, Gursoz H, Artiran G, Kerman S. Impact of Health Policy Changes on the Growth Locally Manufactured and Imported Pharmaceutical Markets In Turkey. Value Health 2014; 17:A410. [PMID: 27201006 DOI: 10.1016/j.jval.2014.08.967] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Affiliation(s)
- Vural E Hilal
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - G Kockaya
- Health Economics and Policy Association, Ankra, Turkey
| | | | - M Saylan
- Health Economics and Policy Association, Ankra, Turkey
| | - Yilmaz E Safak
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - M Tatar
- Hacettepe University, Ankara, Turkey
| | - I M Vural
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - A Akbulat
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - H Gursoz
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - G Artiran
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - S Kerman
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| |
Collapse
|
|
7
|
Yenilmez FB, Kockaya G, Saylan M, Safak YE, Tatar M, Hilal VE, Vural IM, Akbulat A, Gursoz H, Artiran G, Kerman S. Impact of Health Policy Changes on the Cost Sales of 5 Top Selling ATC1 Phramaceutical Groups in Turkey. Value Health 2014; 17:A410. [PMID: 27201009 DOI: 10.1016/j.jval.2014.08.964] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Affiliation(s)
| | - G Kockaya
- Health Economics and Policy Association, Ankra, Turkey
| | - M Saylan
- Health Economics and Policy Association, Ankra, Turkey
| | - Yilmaz E Safak
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - M Tatar
- Hacettepe University, Ankara, Turkey
| | - Vural E Hilal
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - I M Vural
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - A Akbulat
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - H Gursoz
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - G Artiran
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - S Kerman
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| |
Collapse
|
|
8
|
Akbulat A, Dogan E, Babacan S, Uman N, Tolun C, Vural IM, Vural EH, Safak YE, Dasdag MM, Kahveci R, Malhan S, Artiran G, Kerman S. Characteristics of The Medicines Which Have Annual Average Highest Amount Of Sales Of Between Years 2008-2013. Value Health 2014; 17:A411. [PMID: 27201011 DOI: 10.1016/j.jval.2014.08.970] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Affiliation(s)
- A Akbulat
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - E Dogan
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - S Babacan
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - N Uman
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - C Tolun
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - I M Vural
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - E H Vural
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - Yilmaz E Safak
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - M M Dasdag
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - R Kahveci
- Ankara Numune Education and Research Hospital, Ankara, Turkey
| | - S Malhan
- Baskent University, Ankara, Turkey
| | - G Artiran
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - S Kerman
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| |
Collapse
|
|
9
|
Safak YE, Kockaya G, Yenilmez FB, Saylan M, Tatar M, Hilal VE, Vural IM, Akbulat A, Gursoz H, Artiran G, Kerman S. Impact of Health Policy Changes on Trends of Pharmaceutical Market in Turkey. Value Health 2014; 17:A408. [PMID: 27200995 DOI: 10.1016/j.jval.2014.08.957] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Affiliation(s)
- Yilmaz E Safak
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - G Kockaya
- Health Economics and Policy Association, Ankra, Turkey
| | | | - M Saylan
- Health Economics and Policy Association, Ankra, Turkey
| | - M Tatar
- Hacettepe University, Ankara, Turkey
| | - Vural E Hilal
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - I M Vural
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - A Akbulat
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - H Gursoz
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - G Artiran
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - S Kerman
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| |
Collapse
|
|
10
|
Uman N, Tolun C, Babacan S, Dogan E, Vural IM, Vural EH, Dasdag MM, Safak YE, Malhan S, Kahveci R, Akbulat A, Artiran G, Kerman S. Effects of Reference Price System on Medicines Which Have Annual Average Highest Amount Of Sales Of Between Years 2008-2013. Value Health 2014; 17:A409. [PMID: 27201003 DOI: 10.1016/j.jval.2014.08.959] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Affiliation(s)
- N Uman
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - C Tolun
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - S Babacan
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - E Dogan
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - I M Vural
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - E H Vural
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - M M Dasdag
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - Yilmaz E Safak
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - S Malhan
- Baskent University, Ankara, Turkey
| | - R Kahveci
- Ankara Numune Education and Research Hospital, Ankara, Turkey
| | - A Akbulat
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - G Artiran
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| | - S Kerman
- Turkish Medicines and Medical Devices Agency, Ankara, Turkey
| |
Collapse
|
|
11
|
Aydinkarahaliloglu ND, Aykac E, Kasap Y, Durmus N, Babacanoglu C, Basgut CE, Artiran G, Kerman S. Pharmaceutical risk management in Turkey: the first national overview. Regul Toxicol Pharmacol 2013; 67:344-50. [PMID: 23994623 DOI: 10.1016/j.yrtph.2013.08.012] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/16/2013] [Accepted: 08/17/2013] [Indexed: 11/26/2022]
Abstract
Risk management plans and actions aim to limit the known risks of drugs and provide valuable data to evaluate actual risks and pre-disposing factors for adverse drug reactions. In this study, it is aimed to evaluate and summarize the risk management actions in Turkey between 2005 and 2013 for the first time. The drugs monitored with a risk management plan and actions taken are evaluated by examining the records of the Turkish Pharmaceuticals and Medical Devices Agency retrospectively. Various risk management actions such as provision of information, summary of product characteristics and patient information leaflets, direct communication with healthcare professionals, patient and physician brochures, change of the legal status of the drug, education of doctors and pharmacists, control of number and validity of prescriptions, using informed consent forms, using "drug safety surveillance form" for the TNF blockers (firstly on the world), using web-based monitoring system, web-based prescription and web-based adverse reaction monitoring system were used for safe use of drugs during and after authorization in Turkey. Although, most of the actions are similar to those of international health authorities, the remaining are specific to the conditions of Turkey such as "drug safety surveillance form" for the TNF blockers.
Collapse
Affiliation(s)
- N D Aydinkarahaliloglu
- Department of Risk Management, Turkish Medicines and Medical Devices Agency, Ankara 06520, Turkey
| | | | | | | | | | | | | | | |
Collapse
|